A chemical worker working with urea-formaldehyde resin hazard for 20 years suffered cerebral ischemia in association with an increase of blood beta2-glycoprotein I-dependent anticardiolipin antibody (aCL)-IgG and IgM isotype, and a prolongation of activated partial thromboplastin time (aPTT). Major histocompatibility complex antigen showed DR4 positivity. On follow-up for over 6 years, aCL-IgG and aPTT decreased to reference range but aCL-IgM was still abnormally high despite a cessation of exposure. This patient highlights the induction of antibody-mediated thrombosis in chronic chemical exposure, especially in an individual with subclinical autoimmune disorder. The role of environment for coagulopathic vascular thrombosis is warranted for investigation.
Chiou HY, Huang WI, Su CL, et al.Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke1997;28:1717-1717.
2.
Yang CY.Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke1998;29:411-411.
3.
Hong YC, Lee JT, Kim H, Kwon HJ.Air pollution: A new risk factor in ischemic stroke mortality. Stroke2002;33:2165-2165.
4.
Huang CC, Chu CC, Chu NS, Wu TN.Carbon disulfide vasculopathy: A small vessel disease. Cerevbrovasc Dis2001;11:245-245.
5.
Chen WH, Kao YF, Lan MY, et al.A perturbation of antithrombin III and protein C coupling associates with an increase of anti-beta2-glycoprotein I antibody in non-antiphospholipid antibody syndrome in cerebral ischemia. Blood Coag Fibrinolysis2003;13:703-703.
6.
Chen WH, Lan MY, Chang YY, et al.The prevalence of protein C, protein S, and antithrombin III deficiency in non-APS/SLE Chinese adults with noncardiac cerebral ischemia. Clin Appl Thromb Hemost2003;9:155-155.
Tuhrim S, Rand JH, Wu XX, et al.Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke1999;30:1561-1561.
9.
Sestakov NM, Sarankin GE, Irvanov EA, et al.Impact of the products of urea-formaldehyde resin break-down on the cardiovascular system of foundry workers [Rus]. Gigiena truda I professional’nye zabolevanija Gigiena truda i professional’nye zabolevanija1987;7:32-32.
10.
Kim WJ, Terada N, Nomura T, et al.Effect of formaldehyde on the expression of adhesion molecules in nasal microvascular endothelial cells: the role of formaldehyde in the pathogenesis of sick building syndrome. Clin Exp Allergy2002;32:287-287.
11.
Tyihak E, Bocsi J, Timar F, et al.Formaldehyde promotes and inhibits the proliferation of cultured tumour and endothelial cells. Cell Prolif2001;34:135-135.
12.
Yu PH, Lai CT, Zuo DM.Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res1997;22:615-615.
Teng S, Beard K, Pourahmad J, et al.The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chem Biol Interact2002;130-130.
15.
Pross HF, Day JH, Clark RH, Lees RD.Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products. J Allergy Clin Immunol1987;79:797-797.
16.
Madison RE, Broughton A, Thrasher JD.Immunologic biomarkers associated with an acute exposure to exothermic byproducts of a ureaformaldehyde spill. Environ Health Perspect1991;94:219-219.
17.
Krause I, Blank M, Levi Y, et al.Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol1999;117:190-190.
18.
Wilson WA.Family studies and the major histocompatibility complex. In: Khamashta MA, ed. Hughes Syndrome: Antiphospholipid Syndrome. Springer: New York, 2000, p. 348-348.
19.
Cnosa RT, Lewis ME, Yunis EJ.Associations of HLA-Bw44 with chloropromazine-induced autoantibodies. Clin Immunol Immunopathol1982;25:278-278.
